Hamilton Regional Laboratory Medicine Program

Transcription

1 Created: April 2002 of Review: February 2004 of Review: June 2006 of Review: July 2007, St. Joseph s Healthcare went live with Meditech as of June18, of Review: August 2009 of Review: December 2011; updates made June 2012; further updates made due to New Chemistry Instrument November 2012 Leukocytes x10 9 /L Erythrocytes x10 12 /L x10 12 /L Hemoglobin g/l g/l Hematocrit L/L L/L MCV fl MCH pg MCHC g/l R.D.W % 31/01/08 Platelets x10 9 /L M.P.V fl Relative Neutrophils 24/01/08 Relative Lymphocytes 24/01/08 Relative Monocytes 24/01/08 Relative Eosinophils 24/01/08 Relative Basophils 24/01/08 Page 1 of 10 Printed on 3/20/2014

2 Absolute Neutrophils x10 9 /L 24/01/08 Absolute Lymphocytes x10 9 /L Absolute Monocytes x10 9 /L Absolute Eosinophils x10 9 /L Absolute Basophils x10 9 /L Reticulocyte Count x10 9 /L Erythrocyte Sedimentation Rate 0-15 mm/h 28/06/ mm/h Vitamin B pmol/l ERC Folate <520 Deficient 07/02/07 PT in INR Therapeutic Range: Mechanical mitral and high-risk aortic values: APTT s Heparin Therapeutic Range: 60-85s aptt values <19 seconds can reflect insufficient sample anticoagulant, due to anemia, and/or hypercalcemia. Please contact the Coagulation to arrange repeat testing using adjusted anticoagulation collection tubes, if clinically indicated. Clauss Fibrinogen g/l TCT 2 unit s D-Dimer <500 ug/l FEU Quantitative Method used for exclusion of DVT / PE) Albumin g/l Alkaline Phosphatase U/L ALT U/L U/L 23/02/05 (Mechanical valve 06/06/06) 17/11/04 06/07/11 Page 2 of 10 Printed on 3/20/2014

3 Ammonia Amylase <100 U/L Apolipoprotein A g/l g/l Apolipoprotein B g/l g/l AST <35 U/L Beta-hCG, Total <5 IU/L Bile Acid, Total <6.7 21/04/11 Bilirubin, Conjugated 8.6 Bilirubin, Total <21 Blood Gases: H+ Arterial ph Arterial pco2 Arterial mmhg po2 Arterial mmhg Bicarbonate Calculated mmol/l 23/10/09 Base Excess -2 to +3 mmol/l O2 Saturation Measured Arterial Fract Carboxyhemoglobin Fract Heavy smokers may show up to 0.10 Methemoglobin Fract Methemoglobin levels >0.1 are compatible with cyanosis CA U/mL Calcium (total) mmol/l Carotene /01/09 Chloride mmol/l Page 3 of 10 Printed on 3/20/2014

4 Cholesterol mmol/l Target Values: 20/06/12 Desirable Total Cholesterol: <5.20 mmol/l High Risk / Secondary CVD Prevention: 4.00 mmol/l CK (Creatine Kinase) <200 U/L <168 U/L CK-2 (CKMB) ug/l ug/l Page 4 of 10 Printed on 3/20/2014 Study use only. No longer available. Total CO mmol/l Cortisol h Specimen h Specimen < h Specimen C-Peptide pmol/l 15/10/07 Creatinine C-Reative Protein 5.0 mg/l DHEA-Sulphate , years, years, years, years, years, 70 years, years, years, years, years, years, 70 years

5 Digoxin Therapeutic Range in Heart Failure: 20/06/ Toxic (>6 hours post-ingestion): >2.6 Estradiol <162 pmol/l Follicular: pmol/l Mid Cycle: pmol/l Luteal: pmol/l Post Menopausal (no HRT): <103 pmol/l Post Menopausal (on HRT): <529 pmol/l Ferritin <23 ug/l Probably iron deficient 12/07/ ug/l Possibly iron deficient ug/l Probably not iron deficient ug/l Not iron deficient >400 ug/l Possibly iron overload Follicle Stimulating Hormone IU/L Follicular: IU/L Mid-cycle: IU/L Luteal: IU/L Fructosamine Postmenopausal: IU/L Fructosamine concentrations reflect glucose status over the previous 3 weeks. Dysproteinemic states may produce erroneous fructosamine values. Page 5 of 10 Printed on 3/20/2014

6 Gastrin, Fasting ng/l 01/12/04 GGT (Gamma Glutamyl Transpeptidase) <65 U/L <37 U/L Glucose, Fasting mmol/l Normal Impaired FBG 7.0 Abnormal FBG Glucose, Random mmol/l 20/06/12 HbA1C Fract. HDL -Cholesterol mmol/l Target Values: 1.30 mmol/l Desirable <1.04 mmol/l Low HDL-C (Increases risk of CVD) 1.55 mmol/l High HDL-C (Optimal) 20/06/12 Human Growth Hormone 3.0 ug/l 19/04/ ug/l IgA g/l IgD mg/l 19/08/13 IgE <120 x103u/l IgG g/l IgM g/l Insulin <120 pmol/l Fasting 21/07/10 Iron Iron Binding Capacity Iron Saturation Fract. Lactate mmol/l LD (Lactate Dehydrogenase) U/L Page 6 of 10 Printed on 3/20/2014

7 LDL - Cholesterol mmol/l Target Values: <2.00 mmol/l for High and Moderate CVD risk or 50% reduction in LDL-C Low risk <3.4 mmol/l 20/06/12 Lipase <79 U/L Lipoprotein (a) <250 mg/l Low Risk mg/l Moderate Risk >350 mg/l High Risk Lithium mmol/l Toxic: >1.5 mmol/l 20/06/12 Magnesium mmol/l Osmolality mmol/kg Parathyroid Hormone (PTH Intact) pmol/l Phosphate mmol/l Potassium mmol/l Pre-Albumin mg/l Progesterone <0.7 Progesterone reference interval varies with menstrual cycle. Folicular Phase: <1.0 Luteal Phase: Postmenopausal: <0.7 1st Trimester: nd Trimester: Hydroxy Progesterone <2.1 3rd Trimester: , Folicular, Luteal, Post Menopausal 11/10/05 Page 7 of 10 Printed on 3/20/2014

8 PSA, Total <4.0 ug/l Sodium mmol/l Testosterone, Free pmol/l, years pmol/l, years pmol/l, years pmol/l, years pmol/l, 60 years pmol/l, years pmol/l, 60 years Testosterone, Total , years, 50 years, Ovulating, Post-menopausal 17/03/11 Theophylline Thyroxine (T4) Thyroxine, Free pmol/l T3 Triiadothyronine, Free (T3, Free) pmol/l T3 Triiadothyronine (Total T3) nmol/l Total Protein g/l Transferrin g/l g/l Triglycerides <1.70 mmol/l High Triglycerides increases risk for CVD; 20/06/12 >10 mmol/l increases risk for pancreatitis Troponin T Not available Troponin I <0.04 ug/l TSH (Thyrotropin) mu/l Urate (Uric Acid) Page 8 of 10 Printed on 3/20/2014

9 mmol/l, years 14/12/12 mmol/l, years mmol/l, 50 years mmol/l, 50 years Urea Valporic Acid Hydroxy Vitamin D <25 Vitamin D deficiency Sub-optimal Vitamin D Status >75 Desirable Vitamin D status >250 Potential Adverse effects 01/04/12 Urinalysis: Routine: Glucose Ketones Specific Gravity /06/12 Blood ph Protein Nitrates Leukocyte Screen Microscopic: Ercs 0-3 /HPF Lkcs 0-5 /HPF Epithelial Cells No Defined Reference Range Page 9 of 10 Printed on 3/20/2014

10 Urine Bilirubin Urobilinogen EU/dL Normally present in urine at concentrations up to 1EU/dL Sputum No Defined Reference Range Cultures are processed and reported for pathogens clinically significant for the site collected; normal (colonizing) flora is not considered clinically significant. Josephine Baldwin Josephine Baldwin Laboratory Research Coordinator Page 10 of 10 Printed on 3/20/2014